Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai. The ...

Latest research on parenting. Everything from infancy through the teen years, including breastfeeding, colic, academic success, behavioral problems, teen relationships and more.